Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Caixia

Caixia Jiang, Beijing CN

Patent application numberDescriptionPublished
20140281030Virtual Network Flow Monitoring - Embodiments perform end-to-end virtual network flow monitoring in a virtual datacenter and provide differentiated views to users based on user role. A target flow pattern describing data packets of interest is distributed to a plurality of applications managing VMs in the virtual datacenter, such as hosts, virtual gateways, and other virtual network applications. Each of the applications monitors data packets routed by the application by comparing the data packets to the flow pattern and selectively collecting context data describing the data packets. The context data collected by the applications is aggregated at a remote server for analysis and reporting.09-18-2014
20150058463PROXY METHODS FOR SUPPRESSING BROADCAST TRAFFIC IN A NETWORK - Some embodiments use proxies on host devices to suppress broadcast traffic in a network. Each host in some embodiments executes one or more virtual machines (VMs). In some embodiments, a proxy operates on each host between each VM and the underlying network. For instance, in some of these embodiments, a VM's proxy operates between the VM and a physical forwarding element executing on the VM's host. The proxy monitors the VM's traffic, and intercepts broadcast packets when it knows how to deal with them. The proxy connects to a set of one or more controllers that provides a directory service that collects and maintains global information of the network. By connecting to the controller cluster, the proxy can obtain information that it can use to resolve broadcast requests. In some embodiments, the connection between the proxy and the controller cluster is encrypted and authenticated, to enhance the security. Also, in some embodiments, the connection is an indirect connection through an agent that executes on the host device and connects the proxies of the host device with the controller cluster.02-26-2015
20150058968PROXY METHODS FOR SUPPRESSING BROADCAST TRAFFIC IN A NETWORK - Some embodiments use proxies on host devices to suppress broadcast traffic in a network. Each host in some embodiments executes one or more virtual machines (VMs). In some embodiments, a proxy operates on each host between each VM and the underlying network. For instance, in some of these embodiments, a VM's proxy operates between the VM and a physical forwarding element executing on the VM's host. The proxy monitors the VM's traffic, and intercepts broadcast packets when it knows how to deal with them. The proxy connects to a set of one or more controllers that provides a directory service that collects and maintains global information of the network. By connecting to the controller cluster, the proxy can obtain information that it can use to resolve broadcast requests. In some embodiments, the connection between the proxy and the controller cluster is encrypted and authenticated, to enhance the security. Also, in some embodiments, the connection is an indirect connection through an agent that executes on the host device and connects the proxies of the host device with the controller cluster.02-26-2015

Caixia Li, Beijing CN

Patent application numberDescriptionPublished
20090018062Malignant tumor-inhibiting preparation comprising des a fibrin - A malignant tumor-inhibiting preparation is provided which comprises Des A fibrin and therefore can inhibit the spreading and migration of malignant tumor cells and thereby can inhibit the malignant tumors.01-15-2009
20100041563METHODS FOR IDENTIFICATION OF ALLELES - The invention provides a method for identification of alleles. In this method, genomic DNA is used as target. Multiple allele-specific PCR amplification are carried out with a group of primers comprising one or more allele-specific primers for a target gene, a universal primer, and a common primer; and a DNA polymerase without 5′ to 3′ exonuclease activity. The PCR products are hybridized with tag probes immobilized on a DNA chip. Results are determined based on the signal intensity and the position of the probe immobilized on the array. Each allele-specific primer comprises a unique tag sequence at the 5′ end. Each tag probe immobilized on the DNA chip comprises a sequence identical to its corresponding tag sequence; and each tag probe hybridizes only with the complementary sequence in the PCR amplification product.02-18-2010
20100220371Security Functional Thin Film and Security Product Containing the Functional Thin Film - The present invention provides a security functional thin film and a security product containing such a thin film. The security functional thin film is of an amorphous structure, and possesses soft magnetic characteristics. Large Barkhausen effect can be detected along the in-plane preferred direction of magnetization; and the Large Barkhausen effect significantly attenuates, or no such signal can be detected, in a direction perpendicular to the in-plane preferred direction of magnetization. The thin film has a thickness of 20-300 nm, and the thin film also possesses element encoding characteristics that can be authenticated by experts. The security functional thin film of the present invention can be fabricated by magnetron sputtering web coating process. The security product provided by the present invention has a security information layer formed of the security functional thin film, and can be combined with other security characteristics for use in fabricating security materials such as security threads, security tapes, paper security strip-like inserts, or security labels, and others. Compared with conventional anti-counterfeiting technologies, the instant security functional thin film has more hidden security information, and facilitates enhancement of safety performance of security products.09-02-2010

Patent applications by Caixia Li, Beijing CN

Caixia Su, Dalian CN

Patent application numberDescriptionPublished
20140112954METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT - The present invention discloses a method for preparing HBV Vaccine comprising aluminum adjuvant, which belongs to biological technology field. The method, which is characterized in that aluminum adjuvant Al(OH)04-24-2014

Caixia Wang, Hebei Province CN

Patent application numberDescriptionPublished
20110002977LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR MANUFACTURING THE SAME - The present invention relates to a liposomal pharmaceutical preparation containing a multivalent ionic drug, a process for the preparation of the liposomal pharmaceutical preparation, and a use thereof in the treatment of diseases, in which the liposome has a size of about 30-80 nm, and the phospholipid bilayer has a phospholipid with a Tm higher than body temperature, so that the phase transition temperature of the liposome is higher than the body temperature.01-06-2011

Caixia Wang, Huizhou CN

Patent application numberDescriptionPublished
20120157130Mobile Terminal Network and Method for Mobile Terminals to Receive Text Messages - The present invention relates to mobile terminal technologies and describes a mobile terminal network and a method for mobile terminals to receive text messages, the method comprising a network server pages a mobile terminal and determines whether text messages can be sent; if the mobile terminal is in the Packet Transfer state, it does not respond to the paging by the network server; if the network server does not receive a response from the mobile terminal, it terminates the paging until receiving position update information from the mobile terminal. After updating the position, the mobile terminal sends position update information to the network server; the network server continues to page the mobile terminal so as to take an action to send text messages. When a mobile terminal is switching in the Packet Transfer state, it can receive and send text messages promptly and rapidly, which ensures that users can receive text is messages promptly.06-21-2012

Caixia Wang, Shijiazhuang CN

Patent application numberDescriptionPublished
20160000726PURIFIED THERAPEUTIC NANOPARTICLES AND PREPARATION METHODS THEREOF - Purified therapeutic nanoparticles are provided herein. Such nanoparticles comprise an active pharmaceutical ingredient and human serum albumin, wherein the weight ratio of human serum albumin to the active ingredient in the therapeutic nanoparticles is from 0.01:1 to 1:1, and wherein the nanoparticles are substantially free of free human serum albumin that is not incorporated in the nanoparticles. The present disclosure also provides pharmaceutical compositions that comprise the purified therapeutic nanoparticles and are also substantially free of free human serum albumin. Methods for preparing and using the purified therapeutic nanoparticles and compositions thereof are also provided.01-07-2016
Website © 2016 Advameg, Inc.